The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Pharmacological PPARγ modulation regulates sebogenesis and inflammation in SZ95 human sebocytes
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“PPARγ acts as a central regulator of sebocyte differentiation and lipogenesis, and dysregulation of this pathway is a hallmark of acne pathophysiology [53].”
From Dissolvable silk microneedles delivering minocycline-loaded ZIF-8 nanoparticles for targeted modulation of sebocyte metabolism and improved acne therapy (2026) · cites this paper as [53]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A RAPID METHOD OF TOTAL LIPID EXTRACTION AND PURIFICATION
Bligh, E. G., & Dyer, W. J. (1959) · Canadian Journal of Biochemistry and Physiology · doi:10.1139/o59-099 · Cited by 54,751
Peroxisome proliferator-activated receptors in inflammation control
Delerive, P., Fruchart, J., & Staels, B. (2001) · Journal of Endocrinology · doi:10.1677/joe.0.1690453 · Cited by 755
New developments in our understanding of acne pathogenesis and treatment
Kurokawa, I., Danby, F. W., Ju, Q., Wang, X., Xiang, L. F., Xia, L., Chen, W., Nagy, I., Picardo, M., Suh, D. H., et al. (2009) · Experimental Dermatology · doi:10.1111/j.1600-0625.2009.00890.x · Cited by 584
Self-citationAcne and sebaceous gland function
Zouboulis, C. C. (2004) · Clinics in Dermatology · doi:10.1016/j.clindermatol.2004.03.004 · Cited by 561
Self-citationNagy, I., Pivarcsi, A., Kis, K., Koreck, A., Bodai, L., McDowell, A., Seltmann, H., Patrick, S., Zouboulis, C. C., & Kemény, L. (2006) · Microbes and Infection · doi:10.1016/j.micinf.2006.04.001 · Cited by 375
Self-citationAlestas, T., Ganceviciene, R., Fimmel, S., Müller-Decker, K., & Zouboulis, C. C. (2006) · Journal of Molecular Medicine · doi:10.1007/s00109-005-0715-8 · Cited by 269
Self-citationLinking diet to acne metabolomics, inflammation, and comedogenesis: an update
Melnik, B. (2015) · Clinical, Cosmetic and Investigational Dermatology · doi:10.2147/ccid.s69135 · Cited by 259
Targeting Peroxisome Proliferator-Activated Receptors (PPARs): Development of Modulators
Pirat, C., Farce, A., Lebègue, N., Renault, N., Furman, C., Millet, R., Yous, S., Speca, S., Berthelot, P., Desreumaux, P., et al. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm101360s · Cited by 198
Peroxisome Proliferator-Activated Receptors Increase Human Sebum Production
Trivedi, N. R., Cong, Z., Nelson, A. M., Albert, A. J., Rosamilia, L. L., Sivarajah, S., Gilliland, K. L., Liu, W., Mauger, D. T., Gabbay, R. A., et al. (2006) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5700336 · Cited by 184
Mirdamadi, Y., Thielitz, A., Wiede, A., Goihl, A., Papakonstantinou, E., Hartig, R., Zouboulis, C. C., Reinhold, D., Simeoni, L., Bommhardt, U., et al. (2015) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2015.08.001 · Cited by 109
Self-citation
Research works printed but not linked: 43
- Moradi Tuchayi, 2015, Acne vulgaris, Nat. Rev. Dis. Primers, 1, 15029, 10.1038/nrdp.2015.29 · DOI · Paper page
- Ghodsi, 2009, Prevalence, severity, and severity risk factors of acne in high school pupils: a community-based study, J. Invest. Dermatol., 129, 2136, 10.1038/jid.2009.47 · DOI · Paper page
- Makrantonaki, 2011, An update on the role of the sebaceous gland in the pathogenesis of acne, Dermatoendocrinology, 3, 41, 10.4161/derm.3.1.13900 · DOI · Paper page
- Zouboulis, 2014, Acne is an inflammatory disease and alterations of sebum composition initiate acne lesions, J. Eur. Acad. Dermatol. Venereol., 28, 527, 10.1111/jdv.12298 · DOI · Paper page
- Tan, 2015, A global perspective on the epidemiology of acne, Br. J. Dermatol., 172, 3, 10.1111/bjd.13462 · DOI · Paper page
- Bhate, 2013, Epidemiology of acne vulgaris, Br. J. Dermatol., 168, 474, 10.1111/bjd.12149 · DOI · Paper page
- Paraskevaidis, 1998, Polymorphisms in the human cytochrome P-450 1A1 gene (CYP1A1) as a factor for developing acne, Dermatology, 196, 171, 10.1159/000017855 · DOI
- Yang, 2013, Association of HSD17B3 and HSD3B1 polymorphisms with acne vulgaris in Southwestern Han Chinese, Dermatology, 227, 202, 10.1159/000353581 · DOI
- Navarini, 2014, Genome-wide association study identifies three novel susceptibility loci for severe Acne vulgaris, Nat. Commun., 5, 4020, 10.1038/ncomms5020 · DOI
- Agamia, 2016, Skin expression of mammalian target of rapamycin and forkhead box transcription factor O1, and serum insulin-like growth factor-1 in patients with acne vulgaris and their relationship with diet, Br. J. Dermatol., 174, 1299, 10.1111/bjd.14409 · DOI
- Monfrecola, 2016, Mechanistic target of rapamycin (mTOR) expression is increased in acne patients' skin, Exp. Dermatol., 25, 153, 10.1111/exd.12885 · DOI
- Huang, 2014, Growing knowledge of the mTOR signaling network, Semin. Cell Dev. Biol., 36, 79, 10.1016/j.semcdb.2014.09.011 · DOI · Paper page
- Melnik, 2013, Potential role of FoxO1 and mTORC1 in the pathogenesis of Western diet-induced acne, Exp. Dermatol., 22, 311, 10.1111/exd.12142 · DOI · Paper page
- Sertznig, 2008, Peroxisome proliferator-activated receptors (PPARs) and the human skin: importance of PPARs in skin physiology and dermatologic diseases, Am. J. Clin. Dermatol., 9, 15, 10.2165/00128071-200809010-00002 · DOI
- Sertznig, 2011, Peroxisome proliferator-activated receptors (PPARs) in dermatology: challenge and promise, Dermatoendocrinology, 3, 130, 10.4161/derm.15025 · DOI
- Mastrofrancesco, 2014, Preclinical studies of a specific PPARgamma modulator in the control of skin inflammation, J. Invest. Dermatol., 134, 1001, 10.1038/jid.2013.448 · DOI
- Icre, 2006, Functions of the peroxisome proliferator-activated receptor (PPAR) alpha and beta in skin homeostasis, epithelial repair, and morphogenesis, J. Investig. Dermatol. Symp. Proc., 11, 30, 10.1038/sj.jidsymp.5650007 · DOI
- Yessoufou, 2010, Multifaceted roles of peroxisome proliferator-activated receptors (PPARs) at the cellular and whole organism levels, Swiss Med. Wkly., 140, w13071
- Klein, 2007, What are subcutaneous adipocytes really good for?, Exp. Dermatol., 16, 45, 10.1111/j.1600-0625.2006.00519_1.x · DOI
- Nehrenheim, 2013, Dihydrodehydrodiisoeugenol enhances adipocyte differentiation and decreases lipolysis in murine and human cells, Exp. Dermatol., 22, 638, 10.1111/exd.12218 · DOI
- Rosenfield, 1999, Rat preputial sebocyte differentiation involves peroxisome proliferator-activated receptors, J. Invest. Dermatol., 112, 226, 10.1046/j.1523-1747.1999.00487.x · DOI
- Downie, 2004, Peroxisome proliferator-activated receptor and farnesoid X receptor ligands differentially regulate sebaceous differentiation in human sebaceous gland organ cultures in vitro, Br. J. Dermatol., 151, 766, 10.1111/j.1365-2133.2004.06171.x · DOI
- Higgins, 2010, Selective peroxisome proliferator-activated receptor gamma (PPARgamma) modulation as a strategy for safer therapeutic PPARgamma activation, Am. J. Clin. Nutr., 91, 267S, 10.3945/ajcn.2009.28449E · DOI · Paper page
- Ramot, 2014, Advanced inhibition of undesired human hair growth by PPARgamma modulation?, J. Invest. Dermatol., 134, 1128, 10.1038/jid.2013.473 · DOI
- Zouboulis, 1999, Establishment and characterization of an immortalized human sebaceous gland cell line (SZ95), J. Invest. Dermatol., 113, 1011, 10.1046/j.1523-1747.1999.00771.x · DOI · Paper page
- Flori, 2011, 2,4,6-Octatrienoic acid is a novel promoter of melanogenesis and antioxidant defence in normal human melanocytes via PPAR-gamma activation, Pigment Cell. Melanoma Res., 24, 618, 10.1111/j.1755-148X.2011.00887.x · DOI
- Smith, 2008, IGF-1 induces SREBP-1 expression and lipogenesis in SEB-1 sebocytes via activation of the phosphoinositide 3-kinase/Akt pathway, J. Invest. Dermatol., 128, 1286, 10.1038/sj.jid.5701155 · DOI · Paper page
- Smith, 2008, The effect of a low glycemic load diet on acne vulgaris and the fatty acid composition of skin surface triglycerides, J. Dermatol. Sci., 50, 41, 10.1016/j.jdermsci.2007.11.005 · DOI · Paper page
- Renier, 1996, Direct stimulatory effect of insulin-like growth factor-I on monocyte and macrophage tumor necrosis factor-alpha production, Endocrinology, 137, 4611, 10.1210/endo.137.11.8895324 · DOI
- Kooijman, 2003, IGF-I stimulates IL-8 production in the promyelocytic cell line HL-60 through activation of extracellular signal-regulated protein kinase, Cell. Signal., 15, 1091, 10.1016/S0898-6568(03)00069-X · DOI
- Rudman, 1997, The role of IGF-I in human skin and its appendages: morphogen as well as mitogen?, J. Invest. Dermatol., 109, 770, 10.1111/1523-1747.ep12340934 · DOI · Paper page
- Makrantonaki, 2008, Interplay of IGF-I and 17beta-estradiol at age-specific levels in human sebocytes and fibroblasts in vitro, Exp. Gerontol., 43, 939, 10.1016/j.exger.2008.07.005 · DOI
- Graham, 2004, Proinflammatory cytokine production by human keratinocytes stimulated with Propionibacterium acnes and P. acnes GroEL, Br. J. Dermatol., 150, 421, 10.1046/j.1365-2133.2004.05762.x · DOI · Paper page
- Kang, 2005, Inflammation and extracellular matrix degradation mediated by activated transcription factors nuclear factor-kappaB and activator protein-1 in inflammatory acne lesions in vivo, Am. J. Pathol., 166, 1691, 10.1016/S0002-9440(10)62479-0 · DOI · Paper page
- Gollnick, 2014, Not all acne is acne vulgaris, Dtsch. Arztebl Int., 111, 301
- Zouboulis, 2002, Corticotropin-releasing hormone: an autocrine hormone that promotes lipogenesis in human sebocytes, Proc. Natl. Acad. Sci. U.S.A., 99, 7148, 10.1073/pnas.102180999 · DOI · Paper page
- Gupta, 2015, Peroxisome proliferator-activated receptors (PPARs) and PPAR agonists: the 'future' in dermatology therapeutics?, Arch. Dermatol. Res., 307, 767, 10.1007/s00403-015-1571-1 · DOI
- Ramot, 2015, The role of PPARgamma-mediated signalling in skin biology and pathology: new targets and opportunities for clinical dermatology, Exp. Dermatol., 24, 245, 10.1111/exd.12647 · DOI
- Dozsa, 2014, PPARgamma-mediated and arachidonic acid-dependent signaling is involved in differentiation and lipid production of human sebocytes, J. Invest. Dermatol., 134, 910, 10.1038/jid.2013.413 · DOI
- Sears, 2007, Selective modulation of promoter recruitment and transcriptional activity of PPARgamma, Biochem. Biophys. Res. Commun., 364, 515, 10.1016/j.bbrc.2007.10.057 · DOI
- Dozsa, 2016, Decreased peroxisome proliferator-activated receptor gamma level and signalling in sebaceous glands of patients with acne vulgaris, Clin. Exp. Dermatol., 41, 547, 10.1111/ced.12794 · DOI
- Akaza, 2014, Fatty acid compositions of triglycerides and free fatty acids in sebum depend on amount of triglycerides, and do not differ in presence or absence of acne vulgaris, J. Dermatol., 41, 1069, 10.1111/1346-8138.12699 · DOI
- Kwon, 2015, Activity-guided purification identifies lupeol, a pentacyclic triterpene, as a therapeutic agent multiple pathogenic factors of acne, J. Invest. Dermatol., 135, 1491, 10.1038/jid.2015.29 · DOI
Cited by
Del Rosso, J. Q., & Kircik, L. (2024) · Journal of Dermatological Treatment · doi:10.1080/09546634.2023.2296855 · Cited by 68
Yang, X., Ruan, D., Ye, F., Qiu, X., Li, S., Huang, L., Zouboulis, C. C., Mo, X., Jiang, X., & Ju, Q. (2026) · Journal of Nanobiotechnology · doi:10.1186/s12951-026-04221-8 · Cited by 4
Self-citation
Metadata
- Authors
- Mastrofrancesco, A., Ottaviani, M., Cardinali, G., Flori, E., Briganti, S., Ludovici, M., Zouboulis, C. C., Lora, V., Camera, E., & Picardo, M.
- Venue
- Biochemical Pharmacology
- Publisher
- Elsevier BV
- Published
- 2017-08
- Volume
- 138
- Pages
- 96-106
- ISSN
- 0006-2952
- Cited by
- 50
- References
- 10
- Language
- en
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Funders
- Italian Minister of Health
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Pharmacological PPARγ modulation regulates sebogenesis and inflammation in SZ95 human sebocytes. https://app.cochat.ai/papers/10.1016/j.bcp.2017.04.030
- The paper
- Mastrofrancesco, A., Ottaviani, M., Cardinali, G., Flori, E., Briganti, S., Ludovici, M., Zouboulis, C. C., Lora, V., Camera, E., & Picardo, M. (2017). Pharmacological PPARγ modulation regulates sebogenesis and inflammation in SZ95 human sebocytes. Biochemical Pharmacology. https://doi.org/10.1016/j.bcp.2017.04.030
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.